Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
human homolog may play a role in regulation of transcription and splicing. Additionally we are shipping Cdc2-Related Kinase, Arginine/serine-Rich Kits (8) and Cdc2-Related Kinase, Arginine/serine-Rich Proteins (4) and many more products for this protein.
Showing 10 out of 37 products:
Human Polyclonal CRKRS Primary Antibody for IP, WB - ABIN257745
Eifler, Shao, Bartholomeeusen, Fujinaga, Jäger, Johnson, Luo, Krogan, Peterlin: Cyclin-dependent kinase 12 increases 3' end processing of growth factor-induced c-FOS transcripts. in Molecular and cellular biology 2014
Show all 2 Pubmed References
Dog (Canine) Polyclonal CRKRS Primary Antibody for IHC (p) - ABIN271286
Capra, Nuciforo, Confalonieri, Quarto, Bianchi, Nebuloni, Boldorini, Pallotti, Viale, Gishizky, Draetta, Di Fiore: Frequent alterations in the expression of serine/threonine kinases in human cancers. in Cancer research 2006
Cdk12 suppresses genes that support metabolic functions in stressed conditions. Cdk12 is not a generally essential Pol II kinase and is not required for the transcription of essential and housekeeping genes at least in adult tissues.
CDK12 plays a role in controlling the epigenetic transition between euchromatin and heterochromatin, suggesting a chromatin regulatory mechanism in neuronal behaviors.
The phosphorylation of the C-terminal domain of the RNA polymerase II by Cdk12 provides an elegant mechanism in regulating timed splicing of newly synthesized mRNA molecules.
CDK12 gene amplification can contribute to the pathogenesis of breast cancer.
BRCA1 downregulation combined with CHK1 (show CHEK1 Antibodies) inhibition induced excessive amounts of DNA damage, resulting in an inability to complete the S-phase. Therefore, we suggest CHK1 (show CHEK1 Antibodies) inhibition as a strategy for targeting BRCA1- or CDK12-deficient tumors.
In Ovarian Cancer patients CDK12 loss is consistently associated with a particular genomic instability pattern characterized by hundreds of tandem duplications
Structures of CDK12/CycK (show CCNK Antibodies) complexes solved in the presence of AMP (show APRT Antibodies)-PNP (show NP Antibodies).
Data show that most mutations prevent formation of the cyclin-dependent kinase 12 (Cdk12)/cyclin K (CycK (show CCNK Antibodies)) complex, rendering the kinase inactive.
CDK12 affects RNA processing events in two distinct ways: Indirectly through generating factor-binding phospho-epitopes on the CTD of elongating RNAPII (show 0 Antibodies) and directly through binding to specific factors
CDK12 and CDK13 (show CDK13 Antibodies) losses in HCT116 cells preferentially affect expression of DNA damage response.
CDK12 plays an important role in cotranscriptional processing of c-FOS transcripts
CDK12 has properties that should confirm interest in its use as a biomarker.
many CDK12 mutations are an unrecognized cause of HR defects in ovarian cancers
Spontaneous DNA damage was revealed by an increase in 53BP1 (show TP53BP1 Antibodies) foci among cells cultured from Cdk12(-/-) embryos.
Report on the functions of Cdk12 during neural development in vivo, proposes a dual role for Cdk12 in neurogenesis and late stage neuronal migration via 2 distinct pathways
The findings of this study suggest that Cdk12 and Cdk13 (show CDK13 Antibodies) regulate axonal elongation through a common signaling pathway that modulates Cdk5 (show CDK5 Antibodies) expression.
human homolog may play a role in regulation of transcription and splicing
, Cdc2-related kinase, arginine/serine-rich
, CDC2-related protein kinase 7
, cell division cycle 2-related protein kinase 7
, cell division protein kinase 12
, CDC2-related kinase 7
, CDC2-related kinase, arginine/serine-rich
, protein kinase for splicing component
, cyclin-dependent kinase 12 isoform
, cyclin-dependent kinase 12
, Cell division protein kinase 12